Insights

EP. 1: Acute Migraine Management: Overview and Unmet Needs

EP. 2: Goals of and Recommended Approach for Acute Treatment

EP. 3: Acute Migraine Treatment: Pain Freedom and Guidelines

EP. 4: Therapy Assessment: Pain Relief & Onset Monitorization

EP. 5: The Importance of Patient Communication

EP. 6: Recent Approvals for Acute Migraine

EP. 7: The Significance of 5-HT1F Agonist Approval

EP. 8: 5-HT1F Agonist Toxicity Profile and Role in Paradigm

EP. 9: CGRP Receptor Agonists: Safety and Efficacy

EP. 10: The Role of Developing Agents in Acute Migraine Paradigm

EP. 1: Overview of Dravet Syndrome

EP. 2: Importance of Early Diagnosis of Dravet Syndrome

EP. 3: Treatment Options for Dravet Syndrome

EP. 4: Approval of Cannabidiol and Fenfluramine for Dravet

EP. 5: Choosing Cannabidiol or Fenfluramine for Dravet

EP. 6: Future Outlook for Dravet Syndrome

EP. 1: A 55-Year-Old Woman With Epilepsy

EP. 2: Epilepsy Prevalence and Therapy Resistance

EP. 3: Seizure Classification and Goals of Therapy

EP. 4: Antiepileptic Therapy Half-Life, Dosing & Black Box Warning

EP. 5: Antiepileptic Therapy Adverse Effects and Nonadherence

EP. 6: How Treatment Efficacy Is Determined

EP. 7: A Treatment Option for Uncontrolled Partial-Onset Seizures

EP. 8: Real-World Practice: Perampanel for Partial-Onset Seizures

EP. 9: Epilepsy Case Presentation and Diagnostic Process

EP. 10: The Classification of Epilepsy and Seizures

EP. 11: Anticonvulsants to Treat Epilepsy and Alternatives

EP. 12: How Epilepsy Treatment Efficacy Is Determined

EP. 13: Addressing Nonadherence to Therapy

EP. 14: Treating Patients Who Are Unresponsive to Therapy

EP. 1: Burden of Migraine

EP. 2: Acute Migraine Treatment Goals

EP. 3: Advances in the Treatment of Acute Migraine

EP. 4: Rimegepant Treatment for Acute Migraine

EP. 5: Gepants for Acute Migraine: Safety & Efficacy Data

EP. 6: Gepants for Acute Migraine: Patient Management

EP. 7: Real-World Experience With Gepants for Acute Migraine

EP. 8: Acute Migraine Treatment: What’s Next?

EP. 9: Treating Acute Migraine in the Community Setting

EP. 10: Treatment Goals for Acute Migraine

EP. 11: Acute Migraine Treatment Goals

EP. 12: Patient Selection for Acute Migraine Therapy

EP. 13: Rimegepant: Treatment for Acute Migraine

EP. 14: Ubrogepant: Treatment for Acute Migraine

EP. 15: Therapies in Development for Acute Migraine

EP. 1: Overview of OFF Episodes in Parkinson’s Disease

EP. 2: Apomorphine Subcutaneous Injection: Historical Perspective for Off-Episodes in Parkinson’s Disease

EP. 3: Apomorphine Subcutaneous Injection: Efficacy and Administration for Off-Episodes in Parkinson Disease

EP. 4: Apomorphine Subcutaneous Injection: Patient Selection for Off-Episodes in Parkinson Disease

EP. 5: Apomorphine Subcutaneous Injection: Circle of Care Program for Off-Episodes in Parkinson Disease

EP. 6: Recent Approval of Sublingual Apomorphine for Off-Episodes in Parkinson Disease

EP. 7: Continuous Subcutaneous Apomorphine Infusion in Development for OFF Episodes in Parkinson’s Disease

EP. 8: Levodopa Inhalation Powder for OFF Episodes in Parkinson’s Disease

EP. 9: Recently Approved Oral Therapies for OFF Episodes in Parkinson’s Disease

EP. 10: Device-Assisted and Surgical Options for Advanced Motor Fluctuations in Parkinson’s Disease

EP. 11: Treating OFF Episodes in Parkinson’s Disease During COVID-19

EP. 1: Overview of Spinal Muscular Atrophy

EP. 2: Spectrum of SMA Phenotypes at Presentation

EP. 3: Genetic Testing in SMA

EP. 4: Considerations When Diagnosing SMA

EP. 5: Assessing Motor Function in Later-Onset SMA

EP. 6: Multidisciplinary Management of SMA

EP. 7: Nusinersen Treatment for SMA

EP. 8: The ENDEAR and CHERISH Trials in SMA

EP. 9: Nusinersen in Adults With 5q SMA

EP. 10: Real-World Experience Treating SMA With Nusinersen

EP. 11: Risdiplam Under Study to Treat SMA

EP. 12: Drugs in Development and Next Steps

EP. 13: Treating SMA in the Community